Some patients fear tirzepatide, sold by Eli Lilly under the brand names Zepbound and Mounjaro, will be hard to get and prohibitively expensive once compounding pharmacies are no longer producing it.

The FDA became aware of the problem after a patient submitted a complaint to the regulator that a vial of semaglutide from ...

Drugs like Wegovy may trim your waistline but not medical costs, according to an analysis of U.S. health insurance claims ...

Drugs and weight loss often go hand in hand, but the journey can feel overwhelming—especially when your wallet takes a hit.

Unlike others in its class, tirzepatide targets two hormones ... While Ro’s policies won’t cover the program costs, the company will help you determine whether your insurance plan covers ...

As obesity rates in the United States soar, insurance companies, including Medicaid and Medicare, are facing financial ...

A trial, targeted at people living with obesity from Britain to Puerto Rico, is the first head-to-head comparison of the ...

A month’s supply can cost around $936 without insurance ... brand names for semaglutide and tirzepatide, respectively. “My ...

Volkswagen board preparing $4.3B cost-savings plan: report. McDonald's confirms beef patties not to blame for E. coli ...

Prime Minister Keir Starmer and health secretary Wes Streeting have recently discussed plans to trial weight-loss injections ...

Online health platforms continue to advertise access to copycat versions of blockbuster weight-loss drugs Wegovy and Zepbound ...

The costs for a similar control group of patients not taking ... The researchers didn't track long-term use of Lilly's newer ...